Activ-L™ Artificial Disc Treatment of Degenerative Disc Disease in the Treatment of Degenerative Disc Disease

NACompletedINTERVENTIONAL
Enrollment

376

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

December 31, 2012

Study Completion Date

January 31, 2017

Conditions
Degenerative Disc Disease
Interventions
DEVICE

Activ-L Artificial Disc

Implantation at one level of the lumbar spine, either L4/L5 or L5/S1.

DEVICE

ProDisc-L Total Disc Replacement or Charité Artificial Disc

Implantation at one level of the lumbar spine, either L4/L5 or L5/S1.

Trial Locations (17)

10021

Hospital for Special Surgery, New York

16507

Hamot Medical Center, Erie

28203

Carolinas Healthcare, Charlotte

33180

Aventura Hospital and Medical Center, Aventura

33613

University Community Hospital, Tampa

44106

University Hospitals of Cleveland, Cleveland

55109

HealthEast St. John's Hospital, Maplewood

60612

Rush University Medical Center, Chicago

61605

Neurosciences Education and Research Foundation, Peoria

80045

University of Colorado Health Sciences Center, Aurora

84112

University of Utah, Salt Lake City

90404

St. John's Hospital and Health Center, Santa Monica

91730

Rancho Specialty Hospital, Rancho Cucamonga

92037

Scripps Memorial Hospital La Jolla, La Jolla

92658

Hoag Memorial Hospital Presbyterian, Newport Beach

94143

University of California San Francisco, San Francisco

06520

Yale University School of Medicine/New Haven Hospital, New Haven

All Listed Sponsors
lead

Aesculap Implant Systems

INDUSTRY

NCT00589797 - Activ-L™ Artificial Disc Treatment of Degenerative Disc Disease in the Treatment of Degenerative Disc Disease | Biotech Hunter | Biotech Hunter